These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7496287)

  • 1. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.
    Impallomeni M; Galletly NP; Wort SJ; Starr JM; Rogers TR
    BMJ; 1995 Nov; 311(7016):1345-6. PubMed ID: 7496287
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Cefotaxime compares favourably with other third generation cephalosporins.
    Rothschild E; Rauss A; Danan G
    BMJ; 1996 Mar; 312(7033):778. PubMed ID: 8605486
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam.
    Settle CD; Wilcox MH; Fawley WN; Corrado OJ; Hawkey PM
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1217-23. PubMed ID: 9882029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Mortality due to C difficile colitis in elderly people has been underestimated.
    Lesna M; Parham DM
    BMJ; 1996 Mar; 312(7033):778. PubMed ID: 8605487
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly.
    Starr JM; Impallomeni M
    Biomed Pharmacother; 1997; 51(2):63-7. PubMed ID: 9161469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile induced colitis occurring during cefotaxime therapy.
    Green ST; Mackie R; McMillan H; Davie JW
    Ulster Med J; 1985 Apr; 54(1):80-2. PubMed ID: 4082361
    [No Abstract]   [Full Text] [Related]  

  • 7. Hospital-acquired Clostridium difficile diarrhoea and herd immunity.
    Starr JM; Rogers TR; Impallomeni M
    Lancet; 1997 Feb; 349(9049):426-8. PubMed ID: 9033485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of antibiotic prophylaxis in critically ill patients. Antibiotic prophylaxis can lead to contamination with Clostridium difficile.
    Leung D
    BMJ; 1998 Nov; 317(7171):1527. PubMed ID: 9882129
    [No Abstract]   [Full Text] [Related]  

  • 9. Cefotaxime and pseudomembranous colitis.
    Nolan N; Tighe B; Cooney C; O'Briain DS
    Lancet; 1985 Oct; 2(8460):888. PubMed ID: 2864597
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cloudy peritoneal effluent and diarrhoea due to Clostridium difficile].
    Ribés-Cruz JJ; González-Rico M; Juan-García I; Puchades-Montesa MJ; Torregrosa-Maicas I; Ramos-Tomás C; Solís-Salguero MA; Tomás-Simó P; Tejedor-Alonso S; Zambrano-Esteves P; Miguel-Carrasco A
    Nefrologia; 2014; 34(1):130-1. PubMed ID: 24463873
    [No Abstract]   [Full Text] [Related]  

  • 11. Pseudomembranous colitis and cefotaxime.
    Kelly CP; O'Connor R; Weir DG
    Lancet; 1986 Jan; 1(8472):102-3. PubMed ID: 2867303
    [No Abstract]   [Full Text] [Related]  

  • 12. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
    Blondeau JM
    J Antimicrob Chemother; 2009 Feb; 63(2):238-42. PubMed ID: 19028718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Debatable questions on Clostridium difficile diarrhea].
    Burman LG
    Lakartidningen; 1992 Jan; 89(4):196-7. PubMed ID: 1734150
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology of Clostridium difficile infection].
    Szczesny A; Martirosian G
    Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired toxigenic Clostridium difficile diarrhoea in the normoxaemic elderly who have received no antimicrobials: soft evidence for ischaemic colitis?
    Laing RB; Dykhuizen RS; Smith CC; Gould IW; Reid TM
    Scott Med J; 1996 Feb; 41(1):15-6. PubMed ID: 8658116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of Clostridium difficile infection.
    Tonna I; Welsby PD
    Postgrad Med J; 2005 Jun; 81(956):367-9. PubMed ID: 15937201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.
    Bauer MP; Goorhuis A; Koster T; Numan-Ruberg SC; Hagen EC; Debast SB; Kuijper EJ; van Dissel JT
    Neth J Med; 2008 May; 66(5):207-11. PubMed ID: 18490799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-associated diarrhoea and pseudomembranous colitis caused by Clostridium difficile. A review of 40 cases.
    Miller SD; Blake M; Miliotis M; Still C; Taubin A; Koornhof HJ
    S Afr Med J; 1983 Jun; 63(24):936-9. PubMed ID: 6857419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease.
    Patel NS
    BJU Int; 2007 Jun; 99(6):1333-4. PubMed ID: 17233799
    [No Abstract]   [Full Text] [Related]  

  • 20. Clostridium difficile-associated diarrhea in a pediatric hospital.
    Spivack JG; Eppes SC; Klein JD
    Clin Pediatr (Phila); 2003 May; 42(4):347-52. PubMed ID: 12800729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.